Evidence-based Cancer Care: Assessing Multidisciplinary Tumor Board Recommendations and Guideline Adherence in a Non- Academic Medical Center

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Purpose Multidisciplinary tumor boards (MTB) are associated with improved outcomes. Yet, most patients in Western countries receive cancer care at non-academic medical centers. Guideline adherence of MTB recommendations in non-academic medical centers as well as factors contributing to non-adherence have so far not been systematically investigated. Methods All cases discussed at the MTB of the Landesklinikum Baden-Moedling, Austria were eligible for inclusion. Guideline non-adherence was assessed by two reviewers independently using the AWMF S3 guidelines. Factors associated with guideline non-adherence were investigated. Results In total, 579 patients were included in the final analysis: 486 were female (83.9%) and 93 were male (16.1%), with a median age of 70 years (IQR 60–80). Most had breast cancer (n = 451; 77.9%), while 128 had colorectal cancer (22.1%). Complete adherence to guidelines was observed in 453 patients (78.2%), major deviations in 60 (10.4%), and minor deviations in 66 (11.4%) patients. Non-adherence was primarily due to patient preferences (n = 24; 40.0%), lack of surgical treatment recommendation (n = 24; 40.0%), and comorbidities (n = 9; 15.0%). After adjusting for relevant variables, predictors of non-adherence included older age at diagnosis (OR 1.02, 95% CI 1.00-1.04), colorectal cancer (OR 3.84, 95% CI 1.99–7.42), higher ECOG status (OR 1.59, 95% CI 1.18–2.16), and a more recent MTB conference (OR 1.20, 95% CI 1.03–1.41). Conclusion Overall, guideline adherence was high for colorectal and breast cancer and comparable to results from academic medical centers. This study provides support for high-quality cancer treatment in the setting of a non-academic medical center. However, results need to be confirmed in other tumor entities.

Article activity feed